Kistamicin biosynthesis reveals the biosynthetic requirements for production of highly crosslinked glycopeptide antibiotics
0303 health sciences
1300 Biochemistry
Science
Q
Glycopeptides
General Physics and Astronomy
Genetics and Molecular Biology
General Chemistry
1600 Chemistry
540
Article
Anti-Bacterial Agents
Biosynthetic Pathways
3. Good health
Actinobacteria
03 medical and health sciences
Bacterial Proteins
Cytochrome P-450 Enzyme System
Cyclization
Multigene Family
General Biochemistry
Biocatalysis
3100 Physics and Astronomy
Peptides
DOI:
10.1038/s41467-019-10384-w
Publication Date:
2019-06-13T10:02:28Z
AUTHORS (19)
ABSTRACT
AbstractKistamicin is a divergent member of the glycopeptide antibiotics, a structurally complex class of important, clinically relevant antibiotics often used as the last resort against resistant bacteria. The extensively crosslinked structure of these antibiotics that is essential for their activity makes their chemical synthesis highly challenging and limits their production to bacterial fermentation. Kistamicin contains three crosslinks, including an unusual 15-membered A-O-B ring, despite the presence of only two Cytochrome P450 Oxy enzymes thought to catalyse formation of such crosslinks within the biosynthetic gene cluster. In this study, we characterise the kistamicin cyclisation pathway, showing that the two Oxy enzymes are responsible for these crosslinks within kistamicin and that they function through interactions with the X-domain, unique to glycopeptide antibiotic biosynthesis. We also show that the kistamicin OxyC enzyme is a promiscuous biocatalyst, able to install multiple crosslinks into peptides containing phenolic amino acids.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (64)
CITATIONS (59)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....